These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6150331)

  • 21. Killed poliovirus antigen titration in humans.
    Salk J; Cohen H; Fillastre C; Stoeckel P; Rey JL; Schlumberger M; Nicolas A; van Steenis G; van Wezel AL; Triau R; Saliou P; Barry LF; Moreau JP; Mérieux C
    Dev Biol Stand; 1978; 41():119-32. PubMed ID: 753645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
    Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
    Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994.
    Ion-Nedelcu N; Strebel PM; Toma F; Biberi-Moroeanu S; Combiescu M; Persu A; Aubert-Combiescu A; Plotkin SA; Sutter RW
    J Infect Dis; 1997 Feb; 175 Suppl 1():S241-6. PubMed ID: 9203723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge.
    Taffs RE; Chernokhvostova YV; Dragunsky EM; Nomura T; Hioki K; Beuvery EC; Fitzgerald EA; Levenbook IS; Asher DM
    J Infect Dis; 1997 Feb; 175(2):441-4. PubMed ID: 9203668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
    Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.
    J Infect Dis; 1997 Feb; 175 Suppl 1():S215-27. PubMed ID: 9203720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New poliovirus vaccine schedules.
    Zhang Q; Leppold C; Shao Y; Mura Y; Tanimoto T
    Lancet; 2016 Nov; 388(10059):2477-2478. PubMed ID: 27871742
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen.
    Salk J; Stoeckel P; van Wezel AL; Lapinleimu K; van Steenis G
    Ann Clin Res; 1982 Dec; 14(5-6):204-12. PubMed ID: 7171229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization against poliomyelitis.
    Beale AJ
    Br Med Bull; 1969 May; 25(2):148-52. PubMed ID: 4319086
    [No Abstract]   [Full Text] [Related]  

  • 31. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparing the immunogenicity and safety of sequential inoculation of sIPV followed by bOPV (Ⅰ+Ⅲ) in different dosage forms].
    Ye H; Huang T; Ying ZF; Li GL; Che YC; Zhao ZM; Wang JF; Yang XL; Shi L; Jiang RJ; Liu XC; Mo ZJ; Li CG; Yang JS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):43-49. PubMed ID: 29334707
    [No Abstract]   [Full Text] [Related]  

  • 35. The immunological response of Nigerian infants to attenuated and inactivated poliovaccines.
    Oduntan SO; Lucas AO; Wennen EM
    Ann Trop Med Parasitol; 1978 Apr; 72(2):111-5. PubMed ID: 208473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance and control of poliomyelitis in The Netherlands.
    Bijkerk H
    Rev Infect Dis; 1984; 6 Suppl 2():S451-6. PubMed ID: 6330840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of poliomyelitis in Finland.
    Lapinleimu K
    Rev Infect Dis; 1984; 6 Suppl 2():S457-60. PubMed ID: 6330841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial herd immunity to poliomyelitis in a semirural community in South Africa.
    Winter PA; Krynauw JD; Marais GA
    S Afr Med J; 1981 Dec; 60(23):889-90. PubMed ID: 6272430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antipoliomyelitis vaccination of young children with a new inactivated vaccine. Serological results].
    Grenier B; Viarme F; Roumiantzeff M; Xueref C; Demont F
    Arch Fr Pediatr; 1985 Apr; 42(4):321-3. PubMed ID: 4004496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to immunization against polio after allogeneic marrow transplantation.
    Ljungman P; Duraj V; Magnius L
    Bone Marrow Transplant; 1991 Feb; 7(2):89-93. PubMed ID: 1646664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.